Intravenous micellar platform safety review
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This observational study reviews existing patient records to evaluate the safety of an intravenous (IV) investigational product. It helps confirm that the product is safe when given as an IV push or drip.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received the study drug through an IV between June 1, 2025 and April 15, 2026.
- The drug was given from a single-use sterile vial, not a multi-use vial.
- Your medical records include details about the dose, how it was given (IV push or drip), and any side effects after infusion.
- Your records were selected as part of a random, consecutive sample at your clinic.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.
This trial tests a new drug called ICP-538 in healthy people to see how safe it is and how the body processes it. It is an early-phase study that helps decide if the drug can move to testing in patients with a specific condition.
This study tests a new sensor that may help detect when IV fluids leak into the tissue around the injection site. It is for healthy adults to see if the sensor works correctly.
This trial tests a device or method to make IV infusions safer for patients who need fluids or medications through a tube in a vein. It's for adults who already have or will get an IV line for treatments lasting at least 15 minutes.
This study tests a structured clinic visit to help ICU survivors manage medications safely after leaving the hospital. It may reduce the risk of harmful drug effects and improve recovery.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Drug-Related Side Effects and Adverse Reactions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.